戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (left1)

通し番号をクリックするとPubMedの該当ページを表示します
1                                              PIH's experience in Sierra Leone is one of multiple part
2                          However, after 59Fe-PIH uptake 59Fe release from S and R cells was similar.
3          We found that both 59Fe-Tf and 59Fe-PIH uptake were decreased in R cells.
4           The uptake of 59Fe-Tf but not 59Fe-PIH could be blocked by an anti-TfR monoclonal antibody.
5 rean section (OR: 1.7, 95% CI: 1.1, 2.7) and PIH (OR: 1.5, 95% CI: 1.1, 1.9).
6 lex sensitivity (BRS) was impaired in NP and PIH women relative to NN.
7 rtum in women with normal pregnancy (NP) and PIH and in normotensive nonpregnant (NN) women.
8 ation in the pathogenic mechanism of PHH and PIH and highlight promising targets for therapeutic inte
9 arget inflammatory mediators in both PHH and PIH could address the multiple drivers of disease, inclu
10 g, inverse relation between birth weight and PIH risk (p for trend < 0.0001).
11 led non-derepressed-2), occurred during both PIH and CH.
12                           Lessons learned by PIH and its partners in Sierra Leone can contribute to t
13 d contrast to the cellular uptake of (1)(4)C-PIH and (1)(4)C-Bp4eT, which were linear as a function o
14 C-pyridoxal isonicotinoyl hydrazone ((1)(4)C-PIH) and the thiosemicarbazone ((1)(4)C-2-benzoylpyridin
15 cium intake, and women at risk of developing PIH, may benefit from consuming additional dietary calci
16 onversely, the PIH1D1 phospho-binding domain PIH-N is required for association with MRE11 phosphoryla
17  ribosomal and mitochondrial function during PIH and CH.
18 ry metabolite concentrations occurred during PIH and CH.
19 cribe how, in the aftermath of the epidemic, PIH is partnering with the public sector to strengthen t
20 en the risk for laser-induced or exacerbated PIH.
21 en the risk for laser-induced or exacerbated PIH.
22 eight showed a U-shaped relation to risk for PIH, with the highest risks associated with very low and
23 ncluded studies involved laser treatment for PIH with the degree of pigmentation as a measure of outc
24  finger-probe with pulse inversion harmonic (PIH) capability.
25 ow the international NGO Partners In Health (PIH) partnered with the Government of Sierra Leone and W
26 rs of the pyridoxal isonicotinoyl hydrazone (PIH) class can restrict the growth of clinically signifi
27  and 59Fe-pyridoxal isonicotinoyl hydrazone (PIH) to determine whether the decrease in iron uptake by
28 estigation of post-infectious hydrocephalus (PIH) and post-hemorrhagic hydrocephalus (PHH) models rev
29 vors developed postinfectious hydrocephalus (PIH) and 1 (3%) additional survivor had neurodevelopment
30 alus (PHH) and postinfectious hydrocephalus (PIH).
31 tion for postinflammatory hyperpigmentation (PIH) but can pose a clinical dilemma given the risk for
32 tion for postinflammatory hyperpigmentation (PIH) but can pose a clinical dilemma given the risk for
33 tic drive in pregnancy-induced hypertension (PIH) and preeclampsia (PE).
34 treatment of pregnancy-induced hypertension (PIH) is reviewed.
35 ter risk for pregnancy-induced hypertension (PIH), a disorder associated with insulin resistance and
36 litus (GDM), pregnancy-induced hypertension (PIH), emergency cesarean delivery, low birthweight (LBW)
37 tors of phenethylamine-induced hyperthermia (PIH).
38 al of pharmacologically induced hypothermia (PIH) by the novel neurotensin receptor 1 (NTR1) agonist
39 nt in pharmacologically induced hypothermia (PIH).
40 ined this as prolonged intermittent hypoxia (PIH) because the duration of hypoxia in skeletal muscle
41 as shown to also play a contributing role in PIH.
42 similar age and body weight but less than in PIH women (P<0.001) (146+/-23.5 impulses/100 beats).
43                                   NT induces PIH when administered intracerebrally.
44 articularly fetal growth, in the etiology of PIH.
45 ween dietary calcium intake and incidence of PIH.
46                       Screening a library of PIH derivatives revealed that one compound, namely, 2-py
47 cise factors involved in the pathogenesis of PIH are unclear, but several alterations in calcium meta
48 the 22,955 remaining women with no record of PIH.
49 lasers may be beneficial in the treatment of PIH.
50 ce for the use of lasers in the treatment of PIH.
51 lasers may be beneficial in the treatment of PIH.
52 ce for the use of lasers in the treatment of PIH.
53  determine the benefit of laser treatment of PIH.
54 tudies showed no improvement or worsening of PIH after laser treatment.
55 or pharmacological immunomodulation prevents PIH and PHH by antagonizing SPAK-dependent CSF hypersecr
56 mune-epithelial cell cross talk, and reframe PIH and PHH as related neuroimmune disorders vulnerable
57                   These results suggest that PIH induced by neurotensin analogs represented by ABS-20
58                                          The PIH therapy using ABS-201 improves recovery of sensorimo
59                               CE-IOUS in the PIH mode was performed in a standardized protocol (low M
60 duced by the gut microbiome are essential to PIH was tested.
61               Adaptive cellular responses to PIH are not known.
62                                 Responses to PIH induced by three cycles of 8 h hypoxia followed by 1
63 oke are reduced by approximately 30-40% when PIH therapy is initiated either immediately after stroke
64        Cases were 2,180 women diagnosed with PIH.
65       Molecular and metabolic responses with PIH suggest an adaptive exhaustion with failure to resto
66 scribing the successful treatment of SE with PIH.
67      Twenty-one women with NP, 18 women with PIH, and 21 NN women had muscle sympathetic nerve activi